Local Chemotherapy of Esophageal Cancer with Bleomycin Adsorbed to Activated Carbon Particles
Increasing interest has recently been shown in targeting cancer chemotherapy using newly designed drug delivery systems . Hagiwara et al.  developed activated carbon particles as a drug carrier having several advantages such as selective affinity for the lymphatic system and release of a designated fixed concentration of anticancer drug over a long period.
KeywordsLymph Node Esophageal Cancer Regional Lymph Node Mediastinal Lymph Node Gastric Cardia
Unable to display preview. Download preview PDF.
- 2.Hagiwara A, Ahn T, Ueda T, Iwamoto A, Ueda T, Torii T, Takahashi T (1985) Anticancer agents adsorbed by activated carbon particles: A new form of dosage-enhancing efficacy on lymph nodal metastases. Anti-cancer Research 6: 1005–1008Google Scholar